Overview
Rotavirus primarily affects young children, causing severe gastroenteritis characterized by diarrhea, vomiting, and dehydration. It is highly contagious and a significant global health issue, particularly in underdeveloped countries 14.Diagnosis
Management
Special Populations
Key Recommendations
References
1 Aram C, Karami L, Ranjbar MM. Development of a candidate mRNA vaccine based on Multi-Peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach. Scientific reports 2025. link 2 Jeong NY, Cho H, Kim HJ, Choi NK. A broad assessment of rotavirus vaccine safety in infants in Korea: Insights from a data-driven signal detection approach. Human vaccines & immunotherapeutics 2025. link 3 Amin AB, Cates JE, Liu Z, Wu J, Ali I, Rodriguez A et al.. Rotavirus Genotypes in the Postvaccine Era: A Systematic Review and Meta-analysis of Global, Regional, and Temporal Trends by Rotavirus Vaccine Introduction. The Journal of infectious diseases 2024. link 4 Sharma AD, Grewal RK, Gorle S, Cuspoca AF, Kaushik V, Rajjak Shaikh A et al.. T cell epitope based vaccine design while targeting outer capsid proteins of rotavirus strains infecting neonates: an immunoinformatics approach. Journal of biomolecular structure & dynamics 2024. link 5 Almohaimeed HM, Abdulfattah AM, Alsulaimani F, Alshammary A, Almohaini MO, Almehiny KA et al.. Prediction of promiscuous multiepitope-based peptide vaccine against RdRp of rotavirus using immunoinformatics studies. Revista do Instituto de Medicina Tropical de Sao Paulo 2024. link 6 Sharif N, Sharif N, Khan A, Azpíroz ID, Diaz RM, Díez IT et al.. Prevalence and genetic diversity of rotavirus in Bangladesh during pre-vaccination period, 1973-2023: a meta-analysis. Frontiers in immunology 2023. link 7 Stenmarker M, Oldin C, Golsäter M, Blennow M, Enskär K, Nilsson MP et al.. Child health professionals' experiences of the introduction and successful implementation of rotavirus vaccination in Sweden. Acta paediatrica (Oslo, Norway : 1992) 2021. link 8 Haber P, Tate J, Marquez PL, Moro PL, Parashar U. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019. Vaccine 2021. link 9 Price S. Talk to Patients About: Rotavirus. Texas medicine 2019. link 10 . Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007. MMWR. Morbidity and mortality weekly report 2007. link 11 Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?. Pediatrics 2004. link 12 . Suspension of rotavirus vaccine after reports of intussusception--United States, 1999. MMWR. Morbidity and mortality weekly report 2004. link 13 Geier DA, Geier MR. Gastrointestinal reactions and rotavirus vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database for 1999. A model for the calculation of the incidence rates and statistical significance of adverse events following immunization. Hepato-gastroenterology 2004. link 14 McPhillips HA, Davis RL, Marcuse EK, Taylor JA. The rotavirus vaccine's withdrawal and physicians' trust in vaccine safety mechanisms. Archives of pediatrics & adolescent medicine 2001. link 15 Groene WS, Shaw RD. Psoralen preparation of antigenically intact noninfectious rotavirus particles. Journal of virological methods 1992. link90172-a) 16 Abbas AM, Denton MD. An outbreak of rotavirus infection in a geriatric hospital. The Journal of hospital infection 1987. link90099-5) 17 Cubitt WD, Holzel H. An outbreak of rotavirus infection in a long-stay ward of a geriatric hospital. Journal of clinical pathology 1980. link